Compare CRBU & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBU | CURI |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Medicinal Chemicals and Botanical Products | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.6M | 149.4M |
| IPO Year | 2021 | N/A |
| Metric | CRBU | CURI |
|---|---|---|
| Price | $1.82 | $2.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $10.75 | $5.83 |
| AVG Volume (30 Days) | ★ 2.3M | 433.3K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.36% |
| EPS Growth | ★ 3.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.63 | $14.91 |
| Revenue Next Year | $10.93 | $12.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.38 | $2.30 |
| 52 Week High | $3.53 | $5.51 |
| Indicator | CRBU | CURI |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 57.85 |
| Support Level | $1.70 | $2.81 |
| Resistance Level | $2.02 | $3.56 |
| Average True Range (ATR) | 0.12 | 0.15 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 72.22 | 92.59 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.